Table 2.
Recipient characteristics (paired) | Trials | Control | P value |
---|---|---|---|
Age (years) | 40.8 ± 9.2 | 47.1 ± 10.2 | 0.60 |
Sex | |||
Male | 14 | 11 | 0.53 |
Female | 7 | 10 | |
Preoperative Cr (μmol/L) | 1106.4 ± 326.9 | 967.3 ± 236.0 | 0.28 |
Previous transplants | |||
First transplant | 20 | 21 | 1 |
Second transplant | 1 | 0 | |
HLA mismatches | |||
Level 1 | 11 | 9 | 0.76 |
Level 2 | 10 | 12 | |
Pre-emptive dialysis vintage (years) | 2.4 ± 2.2 | 2.1 ± 1.6 | 1 |
Cold ischemia time (h) | |||
< 6 | 14 | 13 | 1 |
6–12 | 7 | 8 | |
Postoperative complications | |||
DGF | 2 | 7 | 0.13 |
AR | 3 | 1 | 0.61 |
Complicated urinary tract infection | 1 | 1 | 1 |
Severe pneumonia | 2 | 5 | 0.41 |
Severe bleeding | 0 | 0 | 1 |
Renal allograft resection or embolism | 1 | 1 | 1 |
Other | 1 | 1 | 1 |
MSC mesenchymal stem cell, Cr creatinine, HLA human leukocyte antigen, DGF delayed graft function, AR acute rejection